Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice.

Susan George, Luke C Cunningham,David P Nelson,Douglas A Horstmanshof,James W Long, Ahmed M El Banayosy

American heart journal plus : cardiology research and practice（2022）

引用 1|浏览4

暂无评分

摘要

This report is among the first to describe the impact of COVID-19 on a diverse advanced HF practice. It highlights the risks associated with COVID-19 faced by the HF, LVAD and HTx patients. A 90-day mortality rate of 19 % with HTx patients acquiring COVID-19 is ominous as is a mortality rate of 12 % each for HF and LVAD patients. This clinical impact should serve as a reminder of unique challenges with these populations.

查看译文

关键词

ACC, American College of Cardiology,AHA, American Heart Association,COVID-19,COVID-19, Coronavirus Disease-2019,HF, Heart Failure,HF-C/D, Stage C or D Heart Failure,HTx, Heart Transplantation,Heart failure,Heart transplantation,LVAD,LVAD, Left Ventricular Assist Device,Mortality,Outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要